Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2002-3-18
pubmed:abstractText
Transforming growth factor beta1 (TGFbeta1) can act as a tumor suppressor or a tumor promoter depending on the characteristics of the malignant cell. We recently demonstrated that colon carcinoma cells transfected with oncogenic cellular K-rasV12, but not oncogenic cellular H-rasV12, switched from TGFbeta1-insensitive to TGFbeta1-growth-stimulated and also became more invasive (Yan, Z., Deng, X., and Friedman, E. (2001) J. Biol. Chem. 276, 1555-1563). We now demonstrate that TGFbeta1 growth stimulation of colon carcinoma cells is Ras-dependent and smad-independent. In U9 colon carcinoma cells, which are responsive to TGFbeta1 by growth stimulation, a truncating mutation at Gln-311 was found in the smad4 gene. Very little smad4 protein was detected in these cells. Loss of smad4 protein was confirmed by functional studies. In U9 cells co-transfected wild-type smad4, but not mutant smad4, mediated response of the 3TP-lux and pSBE promoter reporter constructs to TGFbeta1. Proliferation initiated by TGFbeta1 in U9 cells required Ras-mediated down-regulation of p21cip1 protein. Less p21cip1 was associated with cdk2 small middle dotcyclin complexes in TGFbeta1-treated U9 cells, and the cdk2 complexes had increased kinase activity. Elevation of p21cip1 levels diminished proliferative response to TGFbeta1. U9 cells expressing DN-N17ras neither proliferated in response to TGFbeta1 nor down-regulated the cdk inhibitor p21cip1, and TGFbeta1 activation of 3TP-lux in U9 cells was inhibited by DN-N17ras in a dose-dependent manner. TGFbeta1 also decreased p21cip1 levels and stimulated proliferation in SW480 cells, which express mutant K-Ras but no smad4 protein. TGFbeta1 did not activate or inhibit the p21cip1 promoter construct in U9 cells even in the presence of co-transfected smad4, or alter p21cip1 mRNA levels. Thus the decrease in p21cip1 levels was mediated by a TGFbeta-initiated Ras-dependent, but smad-independent post-transcriptional mechanism.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/CDC2-CDC28 Kinases, http://linkedlifedata.com/resource/pubmed/chemical/CDK2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/CDKN1A protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase 2, http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase Inhibitor..., http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Cyclins, http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Guanosine Diphosphate, http://linkedlifedata.com/resource/pubmed/chemical/Guanosine Triphosphate, http://linkedlifedata.com/resource/pubmed/chemical/Protein-Serine-Threonine Kinases, http://linkedlifedata.com/resource/pubmed/chemical/SMAD4 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Smad4 Protein, http://linkedlifedata.com/resource/pubmed/chemical/TGFB1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Trans-Activators, http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta, http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta1, http://linkedlifedata.com/resource/pubmed/chemical/ras Proteins
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
22
pubmed:volume
277
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
9870-9
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:11784716-Blotting, Northern, pubmed-meshheading:11784716-Blotting, Western, pubmed-meshheading:11784716-CDC2-CDC28 Kinases, pubmed-meshheading:11784716-Cell Division, pubmed-meshheading:11784716-Colonic Neoplasms, pubmed-meshheading:11784716-Cyclin-Dependent Kinase 2, pubmed-meshheading:11784716-Cyclin-Dependent Kinase Inhibitor p21, pubmed-meshheading:11784716-Cyclin-Dependent Kinases, pubmed-meshheading:11784716-Cyclins, pubmed-meshheading:11784716-DNA-Binding Proteins, pubmed-meshheading:11784716-Dose-Response Relationship, Drug, pubmed-meshheading:11784716-Down-Regulation, pubmed-meshheading:11784716-Guanosine Diphosphate, pubmed-meshheading:11784716-Guanosine Triphosphate, pubmed-meshheading:11784716-Humans, pubmed-meshheading:11784716-Mutation, pubmed-meshheading:11784716-Plasmids, pubmed-meshheading:11784716-Protein Binding, pubmed-meshheading:11784716-Protein-Serine-Threonine Kinases, pubmed-meshheading:11784716-RNA Processing, Post-Transcriptional, pubmed-meshheading:11784716-Signal Transduction, pubmed-meshheading:11784716-Smad4 Protein, pubmed-meshheading:11784716-Trans-Activators, pubmed-meshheading:11784716-Transfection, pubmed-meshheading:11784716-Transforming Growth Factor beta, pubmed-meshheading:11784716-Transforming Growth Factor beta1, pubmed-meshheading:11784716-Tumor Cells, Cultured, pubmed-meshheading:11784716-ras Proteins
pubmed:year
2002
pubmed:articleTitle
Transforming growth factor beta 1 induces proliferation in colon carcinoma cells by Ras-dependent, smad-independent down-regulation of p21cip1.
pubmed:affiliation
Pathology Department, Upstate Medical University, State University of New York, Syracuse, New York 13210, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.